Company Data
Defence Therapeutics Inc Cl A
Ticker
DTCFF
Current Price
$0.4114 -5.57%
Market Cap
$23.6M
Price Target
Refer to Report
Volume
500
52wk Range
$0.3086 - $0.7787
Overview
Defence Therapeutics Inc is engaged in the development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases.